ketamine (Psycheceutical Bioscience)

N/A

Report date: 2025/10/29 11:43:24

Base Information

Drug Nameketamine (Psycheceutical Bioscience)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsycheceutical Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesPsycheceutical Bioscience Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A